Synopsis
Synopsis
0
CEP/COS
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 1,3-dimethyl-5-aminoadamantane
2. 1-amino-3,5-dimethyladamantane
3. Axura
4. D 145
5. D-145
6. D145
7. Ebixa
8. Memantin
9. Memantine
10. Namenda
1. 41100-52-1
2. Memantine Hcl
3. Namenda
4. 3,5-dimethyl-1-adamantanamine Hydrochloride
5. 3,5-dimethyladamantan-1-amine Hydrochloride
6. Akatinol
7. Axura
8. Namenda Xr
9. Memary
10. Ebixa
11. Memantine Mylan
12. 1-amino-3,5-dimethyladamantane Hydrochloride
13. Memantine Merz
14. Memantine.hcl
15. Memantine Accord
16. Memantine Lek
17. Memantine (hydrochloride)
18. Acrescent
19. Balaxur
20. Auxura
21. Unii-jy0wd0ua60
22. 3,5-dimethyladamantan-1-amine;hydrochloride
23. Jy0wd0ua60
24. Mfcd00214336
25. Memantine Ratiopharm
26. Memantine Hydrochloride [usan]
27. Chebi:64323
28. Sun-y7017
29. Nsc-102290
30. 3,5-dimethyladamantan-1-aminium Chloride
31. D-145
32. Mls001332605
33. 3,5-dimethyl-1-aminoadamantane Hydrochloride
34. (3,5-dimethyl-1-adamantyl)amine Hydrochloride
35. 3,5-dimethyltricyclo(3.3.1.1(3,7))decan-1-amine Hydrochloride
36. Fp-01
37. 1,3-dimethyl-5-adamantanamine Hcl
38. 3,5-dimethyltricyclo[3.3.1.13,7]decan-1-amine Hydrochloride
39. 41100-52-1 (hcl)
40. Tricyclo[3.3.1.13,7]decan-1-amine, 3,5-dimethyl-, Hydrochloride
41. D 145
42. Mantine
43. Ebixza
44. 3,5-dimethyl-tricyclo[3.3.1.13,7]decan-1-amine Hydrochloride
45. 3,5-dimethyltricyclo(3.3.1.13,7)decan-1-amine Hydrochloride
46. 3,5-dimethyltricyclo(3.3.1.1(sup 3,7))decan-1-amine Hydrochloride
47. Tricyclo(3.3.1.1(sup 3,7))decan-1-amine, 3,5-dimethyl-, Hydrochloride
48. 3,5-dimethyl-1-adamantylamine
49. 3,5-dimethyl-1-aminoadamantane
50. Smr000875213
51. Sr-01000075458
52. Sun Y7017
53. Einecs 255-219-6
54. Namenda (tn)
55. Memary (tn)
56. Marixino
57. Nsc 102290
58. D-145 (hydrochloride)
59. Schembl3053
60. C12h21n.hcl
61. Chembl1699
62. Mls001332606
63. Spectrum1501121
64. Hy-b0365a
65. Dtxsid90961439
66. Memantine Hydrochloride (namenda)
67. N06dx01
68. Nmi-131
69. Hms1571c17
70. Hms1921h03
71. Pharmakon1600-01501121
72. Memantine Hydrochloride (jan/usp)
73. Memantine Hydrochloride [mi]
74. Tox21_500861
75. Ac-559
76. Ccg-39018
77. Memantine Hydrochloride [jan]
78. Mrz-2/145
79. Nsc102290
80. Nsc757843
81. S2043
82. Akos015889460
83. Bcp9000253
84. Lp00861
85. Memantine Hydrochloride [mart.]
86. Nc00680
87. Memantine Hydrochloride [usp-rs]
88. Memantine Hydrochloride [who-dd]
89. Ncgc00094186-01
90. Ncgc00094186-02
91. Ncgc00094186-03
92. Ncgc00261546-01
93. As-13331
94. Bm164662
95. Memantine Hydrochloride [ema Epar]
96. Sy057917
97. 3,5-dimethyladamantan-1-aminehydrochloride
98. Am20070534
99. D3608
100. Eu-0100861
101. Ft-0650723
102. M-145
103. Memantine Hydrochloride [orange Book]
104. Sw060653-4
105. 1-amino-3,5-dimethyl-adamantane Hydrochloride
106. 3,5-dimethyladamantan-1-amine Hy-drochloride
107. 3,5-dimethyladamantan-1-amine;hydrochloride.
108. D04905
109. M 9292
110. Memantine Hydrochloride [usp Monograph]
111. Namzaric Component Memantine Hydrochloride
112. Memantine Hydrochloride Component Of Namzaric
113. Sr-01000075458-1
114. Sr-01000075458-3
115. Sr-01000075458-8
116. Q27133218
117. Z1551429722
118. Tricyclo(3.3.1.1(3,7))decan-1-amine, 3,5-dimethyl-, Hydrochloride
119. Tricyclo[3.3.1.13,7]decan-1-amine, 3,5-dimethyl-, Hydrochloride (1:1) (ca Index Name)
120. 1-amino-3,5-dimethyladamantane . Hcl 3,5-dimethyl-1-aminoadamantane . Hcl Memantine . Hydrochloride
| Molecular Weight | 215.76 g/mol |
|---|---|
| Molecular Formula | C12H22ClN |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 215.1440774 g/mol |
| Monoisotopic Mass | 215.1440774 g/mol |
| Topological Polar Surface Area | 26 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 240 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 6 | |
|---|---|
| Drug Name | Memantine hydrochloride |
| PubMed Health | Memantine (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Tablet |
| Route | oral; Oral |
| Strength | 5mg; 10mg |
| Market Status | Tentative Approval |
| Company | Amneal Pharms; Alembic; Upsher Smith; Mylan Pharma; Unichem Pharms (usa); Apotex; Lupin Pharms; Aurobindo Pharma; Torrent Pharms; Macleods Pharms; Jubilant Life |
| 2 of 6 | |
|---|---|
| Drug Name | Namenda |
| PubMed Health | Memantine (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Tablet; Solution |
| Route | Oral |
| Strength | 2mg/ml; 5mg; 10mg |
| Market Status | Prescription |
| Company | Forest Labs |
| 3 of 6 | |
|---|---|
| Drug Name | Namenda xr |
| Drug Label | NAMENDA XR is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21NHCl and the molecular wei... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 7mg; 14mg; 21mg; 28mg |
| Market Status | Prescription |
| Company | Forest Labs |
| 4 of 6 | |
|---|---|
| Drug Name | Memantine hydrochloride |
| PubMed Health | Memantine (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Tablet |
| Route | oral; Oral |
| Strength | 5mg; 10mg |
| Market Status | Tentative Approval |
| Company | Amneal Pharms; Alembic; Upsher Smith; Mylan Pharma; Unichem Pharms (usa); Apotex; Lupin Pharms; Aurobindo Pharma; Torrent Pharms; Macleods Pharms; Jubilant Life |
| 5 of 6 | |
|---|---|
| Drug Name | Namenda |
| PubMed Health | Memantine (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Tablet; Solution |
| Route | Oral |
| Strength | 2mg/ml; 5mg; 10mg |
| Market Status | Prescription |
| Company | Forest Labs |
| 6 of 6 | |
|---|---|
| Drug Name | Namenda xr |
| Drug Label | NAMENDA XR is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21NHCl and the molecular wei... |
| Active Ingredient | Memantine hydrochloride |
| Dosage Form | Capsule, extended release |
| Route | Oral |
| Strength | 7mg; 14mg; 21mg; 28mg |
| Market Status | Prescription |
| Company | Forest Labs |
Treatment of patients with moderate to severe Alzheimer's disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimer's disease.
Treatment of patients with moderate to severe Alzheimers disease
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of Alzheimers disease
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Dopamine Agents
Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)
Excitatory Amino Acid Antagonists
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06D
N06DA52
Delivering Quality APIs, Drug Intermediates, and Specialty Chemicals to Over 50 Countries Across the Globe.
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-07
Pay. Date : 2012-11-27
DMF Number : 20543
Submission : 2007-05-09
Status : Active
Type : II
Registration Number : 230MF10048
Registrant's Address : 5 Rupnicu Street, Olain, LV-2114, Latvia
Initial Date of Registration : 2018-03-30
Latest Date of Registration :
NDC Package Code : 63818-0004
Start Marketing Date : 2016-05-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Registrant Name : Eltek Pharmachem Co., Ltd.
Registration Date : 2020-05-22
Registration Number : 20200522-209-J-377
Manufacturer Name : JSC OlainFarm
Manufacturer Address : 5, Rupnicu Street, Olaine, LV-2114, Latvia
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-11-13
Pay. Date : 2015-11-05
DMF Number : 20841
Submission : 2007-09-07
Status : Active
Type : II
NDC Package Code : 55111-860
Start Marketing Date : 2010-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-11-23
Pay. Date : 2012-11-09
DMF Number : 20868
Submission : 2007-09-20
Status : Active
Type : II
| Available Reg Filing : CA, ASMF |
JPN Pharma offers excellence in API manufacturing through precision, innovation & quality, delivering solutions to the pharma industry
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-06
Pay. Date : 2013-05-22
DMF Number : 19549
Submission : 2006-06-20
Status : Active
Type : II
NDC Package Code : 17373-1146
Start Marketing Date : 2017-01-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
| Available Reg Filing : ASMF |
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Registration Number : 230MF10010
Registrant's Address : 5 Rupnicu Street, Olain, LV-2114, Latvia
Initial Date of Registration : 2018-01-24
Latest Date of Registration :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-07
Pay. Date : 2012-11-27
DMF Number : 20543
Submission : 2007-05-09
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2015-11-13
Pay. Date : 2015-11-05
DMF Number : 20841
Submission : 2007-09-07
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-23
Pay. Date : 2012-11-09
DMF Number : 20868
Submission : 2007-09-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-06
Pay. Date : 2013-05-22
DMF Number : 19549
Submission : 2006-06-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19024
Submission : 2005-12-14
Status : Inactive
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2013-11-21
Pay. Date : 2013-04-23
DMF Number : 19465
Submission : 2006-05-22
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2013-06-19
Pay. Date : 2013-06-05
DMF Number : 18562
Submission : 2005-07-29
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20151
Submission : 2007-04-02
Status : Inactive
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2013-07-23
Pay. Date : 2013-07-08
DMF Number : 20362
Submission : 2007-03-23
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20388
Submission : 2007-03-30
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Registration Number : 230MF10010
Registrant's Address : 5 Rupnicu Street, Olain, LV-2114, Latvia
Initial Date of Registration : 2018-01-24
Latest Date of Registration : 2018-01-24
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Registration Number : 230MF10048
Registrant's Address : 5 Rupnicu Street, Olain, LV-2114, Latvia
Initial Date of Registration : 2018-03-30
Latest Date of Registration : 2018-03-30
Registration Number : 231MF10017
Registrant's Address : Alembic Road, Vadodara 390 003, Gujarat, India
Initial Date of Registration : 2019-01-28
Latest Date of Registration : 2021-01-20

Registration Number : 231MF10031
Registrant's Address : No. 2066 Tangkou Road, Economy and Technology Development Zone, Hefei, Anhui Province...
Initial Date of Registration : 2019-02-05
Latest Date of Registration : 2023-03-15

Memantine hydrochloride (crushed product)
Registration Number : 230MF10163
Registrant's Address : 1062-8 Honjo, Nishikata-cho, Tochigi City, Tochigi Prefecture
Initial Date of Registration : 2018-12-04
Latest Date of Registration : 2018-12-04

Registration Number : 231MF10038
Registrant's Address : Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (East), Mumbai 4...
Initial Date of Registration : 2019-02-12
Latest Date of Registration : 2019-02-12

Registration Number : 229MF10004
Registrant's Address : Via Matteotti 249,28062 CAMERI (NOVARA)/ITALY
Initial Date of Registration : 2017-01-10
Latest Date of Registration : 2017-01-10

Memantine hydrochloride purified product (crushed product)
Registration Number : 231MF10005
Registrant's Address : 1978-96 Ogushi, Ube City, Yamaguchi Prefecture
Initial Date of Registration : 2019-01-10
Latest Date of Registration : 2019-01-10

Memantine hydrochloride (crushed product)
Registration Number : 231MF10007
Registrant's Address : 1978-96 Ogushi, Ube City, Yamaguchi Prefecture
Initial Date of Registration : 2019-01-10
Latest Date of Registration : 2019-01-10

Registration Number : 231MF10021
Registrant's Address : 333, Jiangnan Road, Hengdian, Dongyang, Zhejiang, 322118, China.
Initial Date of Registration : 2019-01-29
Latest Date of Registration : 2019-01-29

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Date of Issue : 2025-08-08
Valid Till : 2028-07-02
Written Confirmation Number : WC-0081
Address of the Firm : API Division Panelav, At & Post. - Panelav, Tal.

Date of Issue : 2022-09-30
Valid Till : 2025-08-08
Written Confirmation Number : WC-0066
Address of the Firm : Plot No 1, Hetero Infrastructure SEZ Ltd., N. Narasapuram, Anakapalli -531081, A...

Date of Issue : 2025-07-24
Valid Till : 2028-07-02
Written Confirmation Number : WC-0094
Address of the Firm : Plot No. 72 & 82/A, KIADB Industrial Area,\\nJigani, Anekal Taluk,\\nBengaluru-5...

Date of Issue : 2022-06-14
Valid Till : 2025-07-02
Written Confirmation Number : WC-0094nA2A
Address of the Firm : Plot No. 72 & 82/A, KIADB Industrial Area, Jigani, Anekal Taluk, Bengaluru-560 1...

Memantine Hydrochloride IH/USP
Date of Issue : 2022-09-30
Valid Till : 2025-09-10
Written Confirmation Number : WC-0201
Address of the Firm : T-142, MIDC, Tarapur, Boisar, Palghar - 401506, Maharashtra, India

Memantine Hydrochloride IH/USP/EP
Date of Issue : 2025-10-01
Valid Till : 2028-07-02
Written Confirmation Number : WC-0087
Address of the Firm : Plot No.1 to 5, 31 to 35 & 48 to 51, 26 & Kl201, Village Lakhmapur, Taluka Dindo...

Date of Issue : 2025-09-08
Valid Till : 2028-08-15
Written Confirmation Number : WC-0022
Address of the Firm : Plot No. 182 to 186, 192-A and 193 to 197 & 212/A,B,C,D Phase-ll, IDA, Pashamyla...

Date of Issue : 2022-11-08
Valid Till : 2025-02-07
Written Confirmation Number : WC-0153
Address of the Firm : Plot No. L-6, MIDC Taloja, Tal.Panvel, District-Raigad-41 0208, Maharashtra, Ind...

Date of Issue : 2022-06-08
Valid Till : 2025-07-25
Written Confirmation Number : WC-0159nA2
Address of the Firm : A-7/A-8, M.I.D.C Industrial Area, Ahmednagar-414111, Maharashtra, India

Memantine Hydrochloride USP/IH
Date of Issue : 2025-09-19
Valid Till : 2028-07-27
Written Confirmation Number : WC-0062
Address of the Firm : Plot No. 197, Sector -I, Pithampur -454775, District -Dhar (MP), India.

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Registrant Name : Eltek Pharmachem Co., Ltd.
Registration Date : 2020-05-22
Registration Number : 20200522-209-J-377
Manufacturer Name : JSC OlainFarm
Manufacturer Address : 5, Rupnicu Street, Olaine, LV-2114, Latvia
Registrant Name : KR Pharm Co., Ltd.
Registration Date : 2025-06-09
Registration Number : 20181018-209-J-124(9)
Manufacturer Name : Hetero Drugs Limited (Unit-I...
Manufacturer Address : Plot No. 1, Hetero Infrastructure SEZ Ltd, N.Narasapuram Village, Nakkapalli Mandal, ...

Registrant Name : EQ Bio Co., Ltd.
Registration Date : 2025-01-06
Registration Number : 20181018-209-J-124(8)
Manufacturer Name : Hetero Drugs Limited (Unit-I...
Manufacturer Address : Plot No. 1, Hetero Infrastructure SEZ Ltd, N.Narasapuram Village, Nakkapalli Mandal, ...

Registrant Name : Youngjin Pharmaceutical Co., Ltd.
Registration Date : 2025-07-11
Registration Number : 20181018-209-J-124(10)
Manufacturer Name : Hetero Drugs Limited (Unit-I...
Manufacturer Address : Plot No. 1, Hetero Infrastructure SEZ Ltd, N.Narasapuram Village, Nakkapalli Mandal, ...

Registrant Name : Masung LS Co., Ltd.
Registration Date : 2025-04-02
Registration Number : 20250402-209-J-1821
Manufacturer Name : Hikal Limited
Manufacturer Address : 72 & 82/A, KIADB Industrial Area, Jigani, Anekal Taluk, Bangalore- 560105, Karnataka,...

Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2025-06-02
Registration Number : 20250402-209-J-1821(A)
Manufacturer Name : Hikal Limited
Manufacturer Address : 72 & 82/A, KIADB Industrial Area Jigani, Anekal Taluk Bangalore - 560105 Karnataka, I...

Registrant Name : Huseeed Co., Ltd.
Registration Date : 2025-03-26
Registration Number : 20210303-209-J-853(3)
Manufacturer Name : Olon SPA
Manufacturer Address : Via Milano, 186 20024 garbagnate Milanese (MI), Italy

Registrant Name : Lihu Healthcare Co., Ltd.
Registration Date : 2025-03-26
Registration Number : 20250326-209-J-1812
Manufacturer Name : Zhejiang Apeloa Kangyu Pharm...
Manufacturer Address : 333, jiangnan Road, Hengdian Town, Dongyang City, Zhejiang Province, 322118, PR China

Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2025-07-14
Registration Number : 20250326-209-J-1812(1)
Manufacturer Name : Zhejiang Apeloa Kangyu Pharm...
Manufacturer Address : 333, jiangnan Road, Hengdian Town, Dongyang City, Zhejiang Province, 322118, PR China

Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2025-07-28
Registration Number : 20250728-209-J-1959
Manufacturer Name : Shaoxing Jingxin Pharmaceuti...
Manufacturer Address : No.31, Weisan Road, Hangzhou Bay Shangyu Economic and Technological Development Area,...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 702-79-4
End Use API : Memantine Hydrochloride
About The Company : Olpha, the subsidiary of JSC AB City, is one of the largest companies in the Baltic states with 50 years of experience in the production of medicines & chemical...
1-Chloro-3,5-dimethyladamantane
CAS Number : 707-36-8
End Use API : Memantine Hydrochloride
About The Company : Olpha, the subsidiary of JSC AB City, is one of the largest companies in the Baltic states with 50 years of experience in the production of medicines & chemical...
1-Hydroxy-3,5-dimethyladamantane
CAS Number : 707-37-9
End Use API : Memantine Hydrochloride
About The Company : Olpha, the subsidiary of JSC AB City, is one of the largest companies in the Baltic states with 50 years of experience in the production of medicines & chemical...
1-Acetylamido-3,5-dimethyladamantane
CAS Number : 19982-07-1
End Use API : Memantine Hydrochloride
About The Company : Olpha, the subsidiary of JSC AB City, is one of the largest companies in the Baltic states with 50 years of experience in the production of medicines & chemical...
CAS Number : 281-23-2
End Use API : Memantine Hydrochloride
About The Company : Suanfarma is a B2B life sciences company dedicated to health and advancement. To achieve this, the company focuses on developing, manufacturing, and distributin...
CAS Number : 702-79-4
End Use API : Memantine Hydrochloride
About The Company : Cangzhou Enke Pharma Tech Co.,ltd. is located in Cangzhou City, Hebei province ,where is a famous petroleum chemical industry city in China. Enke Pharma a high-...

1-Bromo-3,5-dimethyladamantane
CAS Number : 941-37-7
End Use API : Memantine Hydrochloride
About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...

CAS Number : 702-79-4
End Use API : Memantine Hydrochloride
About The Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technologi...

1,3 -dimethyladamantane
CAS Number : 702-79-4
End Use API : Memantine Hydrochloride
About The Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and ch...

1-Bromo-3,5-Dimethyl adamantine
CAS Number : 941-37-7
End Use API : Memantine Hydrochloride
About The Company : Established in 2011 and situated in Hangzhou, Zhejiang, China, Hangzhou Longshine Bio-Tech CO., Ltd is dedicated to providing services for pharmaceutical and ch...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
99
PharmaCompass offers a list of Memantine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Memantine Hydrochloride manufacturer or Memantine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Memantine Hydrochloride manufacturer or Memantine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Memantine Hydrochloride API Price utilized in the formulation of products. Memantine Hydrochloride API Price is not always fixed or binding as the Memantine Hydrochloride Price is obtained through a variety of data sources. The Memantine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A SUN Y7017 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SUN Y7017, including repackagers and relabelers. The FDA regulates SUN Y7017 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SUN Y7017 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of SUN Y7017 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A SUN Y7017 supplier is an individual or a company that provides SUN Y7017 active pharmaceutical ingredient (API) or SUN Y7017 finished formulations upon request. The SUN Y7017 suppliers may include SUN Y7017 API manufacturers, exporters, distributors and traders.
click here to find a list of SUN Y7017 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A SUN Y7017 DMF (Drug Master File) is a document detailing the whole manufacturing process of SUN Y7017 active pharmaceutical ingredient (API) in detail. Different forms of SUN Y7017 DMFs exist exist since differing nations have different regulations, such as SUN Y7017 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A SUN Y7017 DMF submitted to regulatory agencies in the US is known as a USDMF. SUN Y7017 USDMF includes data on SUN Y7017's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The SUN Y7017 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of SUN Y7017 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The SUN Y7017 Drug Master File in Japan (SUN Y7017 JDMF) empowers SUN Y7017 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the SUN Y7017 JDMF during the approval evaluation for pharmaceutical products. At the time of SUN Y7017 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of SUN Y7017 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a SUN Y7017 Drug Master File in Korea (SUN Y7017 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of SUN Y7017. The MFDS reviews the SUN Y7017 KDMF as part of the drug registration process and uses the information provided in the SUN Y7017 KDMF to evaluate the safety and efficacy of the drug.
After submitting a SUN Y7017 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their SUN Y7017 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of SUN Y7017 suppliers with KDMF on PharmaCompass.
A SUN Y7017 written confirmation (SUN Y7017 WC) is an official document issued by a regulatory agency to a SUN Y7017 manufacturer, verifying that the manufacturing facility of a SUN Y7017 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting SUN Y7017 APIs or SUN Y7017 finished pharmaceutical products to another nation, regulatory agencies frequently require a SUN Y7017 WC (written confirmation) as part of the regulatory process.
click here to find a list of SUN Y7017 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing SUN Y7017 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for SUN Y7017 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture SUN Y7017 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain SUN Y7017 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a SUN Y7017 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of SUN Y7017 suppliers with NDC on PharmaCompass.
SUN Y7017 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SUN Y7017 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SUN Y7017 GMP manufacturer or SUN Y7017 GMP API supplier for your needs.
A SUN Y7017 CoA (Certificate of Analysis) is a formal document that attests to SUN Y7017's compliance with SUN Y7017 specifications and serves as a tool for batch-level quality control.
SUN Y7017 CoA mostly includes findings from lab analyses of a specific batch. For each SUN Y7017 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SUN Y7017 may be tested according to a variety of international standards, such as European Pharmacopoeia (SUN Y7017 EP), SUN Y7017 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SUN Y7017 USP).